Lungpacer Medical Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Burnaby, BC CAN
Total Funding:$19.6M
Industry:Medical Equip
Founded:2009
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Lungpacer Medical's estimated annual revenue is currently $11.8M per year.
  • Lungpacer Medical's estimated revenue per employee is $251,000
  • Lungpacer Medical's total funding is $19.6M.

Employee Data

  • Lungpacer Medical has 47 Employees.
  • Lungpacer Medical grew their employee count by 38% last year.
  • Lungpacer Medical currently has 4 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$9.3M37N/AN/A-N/A
#2
$128.5M512N/AN/A-N/A
#3
$35.1M140N/AN/A-N/A
#4
$26.4M105N/AN/A-N/A
#5
$12.3M4923%N/A-N/A
#6
$59M235N/AN/A-N/A
#7
$12.8M51-32%N/A-N/A
#8
$75.8M302N/AN/A-N/A
#9
$11.8M4738%N/A-N/A
Missing a competitor? Contribute!?
Submit

Lungpacer Medical Inc. is developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle in critically ill patients who require mechanical ventilation. The proprietary Lungpacer system is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach that is expected to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. CAUTION: Investigational device. Not available for sale in any geography.

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

47

Number of Employees

$11.8M

Revenue (est)

4

Current Jobs

38%

Employee Growth %

$19.6M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Lungpacer Medical News

7-Aug-19 - Top Canadian VC deals draw $522 mln in Q2 as focus shifts ...

Life-sciences companies, among them Lungpacer Medical and ABK Biomedical, secured $309 million invested, or a 23 percent share.

11-May-16 - Lungpacer Medical hits the FDA fast track with phrenic nerve ...

Lungpacer Medical said it won an expedited access pathway designation from the FDA for the diaphragm pacing system it's developing to treat ...

6-Sep-19 - Global Phrenic Nerve Stimulation Market to Witness Rapid ...

These factors are responsible and aggravate the medical and R&D ... Biomedical Devices, Inc, Lungpacer Medical Inc. The manufacturers of ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$14M528%N/A-N/A
#2
$5.5M5525%N/A-N/A
#3
$15.4M5714%N/A-N/A
#4
$18.7M5721%N/A-N/A
#5
$15.9M597%N/A-N/A